[go: up one dir, main page]

US8158405B2 - Process for concentrating and processing fluid samples - Google Patents

Process for concentrating and processing fluid samples Download PDF

Info

Publication number
US8158405B2
US8158405B2 US12/215,768 US21576808A US8158405B2 US 8158405 B2 US8158405 B2 US 8158405B2 US 21576808 A US21576808 A US 21576808A US 8158405 B2 US8158405 B2 US 8158405B2
Authority
US
United States
Prior art keywords
recited
microbiological
target
membrane
species
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related, expires
Application number
US12/215,768
Other versions
US20090326211A1 (en
Inventor
Scott Boyette
Rong Xu
Jing Luo
Weiqing Xu
Jing Chen
Weimin Xiao
Tong Chen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BL Technologies Inc
Original Assignee
General Electric Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Electric Co filed Critical General Electric Co
Priority to US12/215,768 priority Critical patent/US8158405B2/en
Assigned to GENERAL ELECTRIC COMPANY reassignment GENERAL ELECTRIC COMPANY ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CHEN, JING, XIAO, WEIMIN, XU, RONG, LUO, JING, CHEN, TONG, XU, WEIQING, BOYETTE, SCOTT
Priority to EP09774004A priority patent/EP2303435A1/en
Priority to PCT/US2009/046755 priority patent/WO2010002552A1/en
Priority to CN200980126140.0A priority patent/CN102076400B/en
Priority to BRPI0910202A priority patent/BRPI0910202A2/en
Priority to CA2728331A priority patent/CA2728331A1/en
Priority to TW098120488A priority patent/TW201009071A/en
Priority to ARP090102286A priority patent/AR072282A1/en
Priority to CL2009001488A priority patent/CL2009001488A1/en
Publication of US20090326211A1 publication Critical patent/US20090326211A1/en
Publication of US8158405B2 publication Critical patent/US8158405B2/en
Application granted granted Critical
Assigned to BL TECHNOLOGIES, INC. reassignment BL TECHNOLOGIES, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: GENERAL ELECTRIC COMPANY
Expired - Fee Related legal-status Critical Current
Adjusted expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/24—Methods of sampling, or inoculating or spreading a sample; Methods of physically isolating an intact microorganisms

Definitions

  • the invention pertains to a process for concentrating fluid samples to obtain biological nucleic acid target materials for analysis.
  • Detection and control of microorganisms are important in many fields including health care, environmental regulation, bio-warfare, pathogen identification, food and drug testing, and in a variety of industrial systems.
  • presence of undesirable microorganisms decreases the efficiency of operating equipment and ultimately increases the cost of associated goods or services.
  • microorganisms multiply rapidly, presence of microbial activity also causes health risks to the public. There is an increasing concern with pathogenic organisms infecting water and process system and creating increased human, animal, and environmental health risk.
  • cooling towers for example, water borne pathogenic microorganisms such as Legionella sp. may be present. If not properly treated with preferred biocides, aerosolized particles containing the microorganisms can create extreme health concerns from inhalation of the aerosolized microorganisms leading to disease such as Pontiac fever or the sometimes fatal Legionnaire's disease caused by Legionella pneumophila . Detection of this microorganism is difficult in the case of open recirculation water systems such as cooling towers because low concentrations represent serious health risk, and large water volumes must be concentrated into smaller sample volumes in order to perform the desired analytical test and obtain accurate and reproducible results.
  • the invention pertains to a method of treating a liquid sample having non-target microbiological particles, inorganic particles, and microbiological target species such as cells or viruses therein.
  • the microbiological target species comprise target materials enveloped therein.
  • the sample is passed through a prefilter medium to allow the target species to pass there through as filtrate. Some of the non-target biological particles and inorganic particles are retained on the prefilter medium.
  • the filtrate from the prefiltering step is contacted by a main filtration medium that is adapted to retain the biological target species thereon as retentate along with other non-target microorganisms.
  • the retentate from the main filtration step is lysed to form a lysate containing the target material.
  • the cell lysate passes through the main filtration medium and is further contacted by a post filtration medium to retain unlysed cells thereon while allowing passage of the target material therethrough as filtrate.
  • the main filtration medium may be pretreated with a retention enhancement agent or agents to improve the retainment of the microbiological target species on the main filter medium.
  • the main filtration medium may be treated with a member or members chosen from the group consisting of surfactants, chelate reagents, salts, and organic solvents. These treatment agents both maintain the integrity of the microbiological target species therein (e.g., cells and viruses) during the main filter capture step and prevent the microbiological target species from irreversibly adhering to the filter material. This assures that a representative sample can be lysed and produce a testing sample that accurately represents the starting material.
  • the present invention relates to a sample collection and processing method including filtration and lysis steps.
  • the method features membranes to filter high volumes of liquid quickly and collect target components in a liquid by a two-step method including a prefiltration step and a main filtration step.
  • the process deploys a post-concentration mechanical or non-mechanical means to release the desired enveloped target material into the solution.
  • the sample solution is then stabilized for downstream analysis.
  • microbiological target species may comprise cellular organisms such as bacteria, algae, fungi, prokaryotes, etc. or viruses.
  • nucleic acid such as DNA or RNA
  • the nucleic acid is located with a protein coat. “Lysing”, as used herein, is then a rupturing of the cells or protein coat to release the desired target nucleic acid material.
  • the method may be used to measure microbiological content.
  • exemplary microorganisms such as bacteria, virus, algae, fungi, and prokaryotes may be measured in accordance with the method.
  • the biological content to be processed in accordance with the methods may be derived from any water or process system such as process water, drinking water, municipal water, cooling water, personal care product manufacturing, in-process pharmaceutical, or food and beverage processes.
  • membranes are employed in a prefiltration system to remove any inorganic particles and large biological particles.
  • the prefiltration membrane or membranes do not retain the target species.
  • This membrane can be any membrane of a variety of a variety of different materials and pore sizes, but preferably one with a controlled pore size that separates at a fixed dimension.
  • Non-limiting examples of prefiltration membrane materials are nylon, stainless steel, cellulose esters, PTFE, glass fibers, polypropylene, polyvinylchloride, hydrophilic acrylic copolymers, polyether sulfones, polycarbonates, and polyesters.
  • Membranes of different pore sizes can be applied depending on the desired end use application.
  • Non-limiting examples of membrane pore size for the prefiltration system are from about 1 ⁇ m, to about 100 ⁇ m, more preferably from about 1 ⁇ m to about 50 ⁇ m, but any membrane that can be used as a prefilter using the instant methods should perform a similar function and should have a well-defined pore size, e.g., a mesh structure to assure that the loss of the target materials on the prefilter membrane is minimized.
  • plural prefiltration membranes can be provided and are arranged in an upstream to downstream flow orientation.
  • the upstream membrane or membranes will have a higher porosity than the downstream membranes.
  • the prefilter serves two purposes. First, it captures larger particles, fungi, algae, and biofilm that, if allowed to transfer to the main membrane, could agglomerate with organics and small particles and inhibit flow. This results in either long filtration times or the inability to filter the total volume required to create a representative sample. Second, the prefilter traps larger life forms like amoeba that are known to harbor Legionella . In one embodiment, the test is for planktonic Legionella , and the amoeba would expel very large numbers of Legionella if lysed.
  • a pair of nylon prefiltration membranes may be used with the upstream membrane in the pair having a pore size of about 20 ⁇ m with the downstream membrane having pores on the order of about 10-11 ⁇ m.
  • the main filtration medium comprises a membrane designed to retain the desired target species.
  • This species may comprise cellular materials or viruses.
  • This membrane can be any member of a different material or pore size.
  • Nonlimiting examples of membranes that may be used as the main filtration medium are nylon, stainless steel, cellulose esters, PTFE, glass fiber, polypropylene, polyvinyl chloride, hydrophilic acrylic copolymer, polyethersulfone, polycarbonate, and polyester.
  • the main filtration membrane functions to retain the target component thereon as retentate.
  • the lysate may be capable of passing through the main filtration medium for subsequent downstream assay or other process.
  • the lysate may be prevented from passing through the main membrane by placing a barrier on the bottom of the membrane.
  • the lysing action may be performed by shaking, and the lysed product may be extracted through a post concentration membrane (e.g., PES 0.2 ⁇ m).
  • the lysate in one embodiment, could be recirculated in a closed system on multiple passes through the main filter for a predetermined recycling time. Then, the lysate continuing the target material nucleic acid could be removed from the recirculation system for subsequent analysis.
  • glass fiber main filtration members may be used and those having pore sizes of between about 10 ⁇ m to about 3.0 ⁇ m may be mentioned as exemplary. More preferred are those main filter membranes having pore sizes on the order of between about 0.7 ⁇ m to about 2.7 ⁇ m.
  • the main membrane pore size requires consideration of two characteristics. First, it must retain the desired target species thereon while not allowing them to stick to the membrane and be lysed to release the enveloped target material during the concentration step. In that case, the target materials such as nucleic acids would be released during the concentration step and be passed with the filtrate. It is desired to keep the target species (e.g., cellular and viral) intact during the concentration step so that they can be lysed during the lysing step. Second, the membrane should have sufficient porosity to assure that a large volume of sample can be filtered in a time that is practical for efficient sample testing.
  • the main filter membrane in accordance with one aspect of the invention, may be treated with chemical or fluidic retention enhancement agents such as surfactants, acids, bases, chelating reagents, salts, organic solvents, etc., to enhance target species retention on the main filtration medium while allowing practical sample flow through the membrane.
  • chemical or fluidic retention enhancement agents such as surfactants, acids, bases, chelating reagents, salts, organic solvents, etc.
  • Suitable surfactants include zwitterionic surfactants, anionic surfactants, cationic surfactants, and nonionic surfactants.
  • the filtration system including both the prefiltration and main filtration media can, in one embodiment, filter quantitative broad volumes of liquid samples with high flow rates.
  • an exemplary sample volume could be 10 liters or more.
  • the sample could be filtered by an integral filtration system with gravity or pressure assistance. Filtration by pressure includes negative pressure and positive pressure.
  • pumps could be used to make negative pressure such as vacuum air pumps, diaphragm liquid pumps, peristatic pumps, etc.
  • the target species such as microbiological contents retained by the main filtration medium, could be used for different applications like physical, chemical, and biological characterization, etc.
  • the main membrane containing the desired target cells is exposed to a lysing buffer designed to produce a small volume of stabilized lysate containing nucleic acid and proteins, etc. for downstream detection such as Polymerase Chain Reaction (PCR), real time PCR, reverse transcription realtime PCR, etc. or other molecular test methods.
  • PCR Polymerase Chain Reaction
  • real time PCR real time PCR
  • reverse transcription realtime PCR etc.
  • Good integrity of the nucleic acid released from the target species can be obtained if the appropriate lysing material is used and can be stabilized in the lysate for 72 hours or more at temperatures of from about 4° C.-43° C.
  • Target species lysing occurs by cell or protein envelope rupture and can be classified as including non-mechanical or mechanical methods.
  • Non-mechanical methods include chemical methods, thermal methods, enzymatic methods, etc.
  • Mechanical methods include ultrasonic disruption using a homogenizer; pressing using, for example, a French press, etc., decompression, pulverization, etc.
  • a non-limiting example is a chemical lysis method that would include any suitable chemical that can disrupt cell or protein envelope barriers.
  • Detergents are a non-limiting example of chemicals that are commonly used to disrupt a lipid double layer membrane to release cell contents and lyse membrane protein, and non-limiting examples of suitable lysing chemicals are lithium dodecyl sulfate, CHAPS, Tween-20E, NP40, CTAB, PVPP, Triton X series detergents, sodium cholate, and sodium deoxycholate, guanidinium hydrochloride, or caustic. Chaotropic agents like guanidiunium salts can also act as lysing agents in this system.
  • lysing efficiency of detergents and alternate lysing agents is dependent on the cell types and specific applications.
  • Enzymes such as lysozymes, mutanolysin, labiase, lysostaphin, lyticase, proteinase K, endolysin and achromopeptidases may be included as lysing reagents or additives to enhance lysing.
  • Organic solvents, such as DMSO, DMF could be also included as lysing reagents or additives to enhance lysing.
  • a host of bioscience suppliers offer a wide collection of lysing buffers suitable for cell lysis application.
  • a variety of physical methods such as shaking, heating, cutting and homogenizing, etc., could be employed in the process to enhance the lysing efficiency. Indeed in one embodiment a cutting action may be employed in which the cells may be ruptured and the main membrane itself will be cut. Based on the complexity of the application and the nature of the target species types, single or combinations of chemical lysis methods could be used in combination with mechanical methods.
  • an additional membrane or membranes could be added to process the cell lysate for downstream application.
  • the membrane could be any membrane of different materials whose pore size is in the range of 0.22 ⁇ m to 0.45 ⁇ m for bacterial, yeast, fungi, or protogen sampling. (Virus sampling will require smaller pore sizes).
  • Non-limited examples of these “post” filtrations membrane materials are PVDF, PES, polycarbonate, nylon, etc. This membrane acts primarily to remove large materials and/or unlysed cells from the sample to enhance long term stability of the lysate at the conditions noted above.
  • Candidate pre-filtration membranes were tested to ascertain their efficacy in allowing passage of the target material, Legionella pneumophila therethrough. Results are shown in terms of percentage of the desired target retained on the prefilter candidates.
  • RNA assay of retained cells was made in order to determine the percent yield.
  • Optimal shaking speeds and lysis time were determined. Based on this data, an optimal shaking speed was determined at 2 ⁇ or at 100 R.P.M. with a total lysis solution contact time of 5 minutes appearing optimal.
  • RNA assay was made to determine the amount of Legionella pneumophila in the lysate.
  • Selected main filter membrane and lysis buffer performance were assessed at different concentrations of the target, Legionella pneumophila cells. No treatment indicates a lack of pretreatment of the filter. STM treatment indicates that the filter was pretreated with the lysis buffering solution.
  • the repeatability of a device integrating the selected membrane and lysis buffer tested 5 log levels of Legionella pneumophila cells.
  • the processes herein described takes less than 15 minutes from the time in which the sample collection is taken to obtain a stabilized biomaterial sample ready for transport to downstream testing.
  • stable extracts from the biomaterials are provided that retain stability for up to 72 hours at temperatures up to about 43° C.
  • the prefiltration and main filtration steps are dead end filtering steps.
  • pretreatment of the main filter medium via surfactants or other retention enhancement agents may be employed.
  • Surfactants may be present in concentration ranges of about 0.5% to about 5%.
  • chelating reagents when utilized to pretreat the main filter membrane, these may be present in concentration of about 0.1 mM to 100 mM. These chelating reagents may comprise for example EDTA and EGTA etc.
  • salts may be used to pretreat the main filtration membrane, and these may be present in an amount of about 1-8 mM solutions, and in those cases in which organic solvents may be utilized for pretreatment of the main filtration medium, these may be present in an amount of about 1-10%.
  • the samples may be incubated at temperatures of about 30° C. to 100° C.
  • electrical fields may be employed to help release the intracellular material.
  • Shaking, inverting, or vibration via impellers and the like may be utilized again as an aid or aids in the lysing operations.
  • Shaking speeds of from about 10-350 RPM may be employed in those instances in which shaking may be found useful to enhance the lysing operation and the lysing operation may generally proceed for anywhere from about between 1 minute to 3 hours.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)

Abstract

A method of treating a liquid sample having microbiological target species therein to concentrate the species and collect lysate is disclosed. The liquid sample comprises non-target microbiological particles, inorganic particles, and microbiological target species. The liquid is passed through a prefilter medium to allow the target species to pass through as filtrate and retain non-target microbiological products and inorganic particles thereon. The filtrate is contacted with a main filtration medium adapted to retain the target species thereon as retentate. The retentate is lysed to form a lysate containing target material that was enveloped within the microbiological target species. The microbiological species may comprise cell containing or viral material. Target materials comprise intracellular nucleic acids, or in the case of viral sampling, nucleic acids encased within the protein sheath or coating of the virus.

Description

FIELD OF INVENTION
The invention pertains to a process for concentrating fluid samples to obtain biological nucleic acid target materials for analysis.
BACKGROUND OF THE INVENTION
Detection and control of microorganisms are important in many fields including health care, environmental regulation, bio-warfare, pathogen identification, food and drug testing, and in a variety of industrial systems. In industry, presence of undesirable microorganisms decreases the efficiency of operating equipment and ultimately increases the cost of associated goods or services. Furthermore, since microorganisms multiply rapidly, presence of microbial activity also causes health risks to the public. There is an increasing concern with pathogenic organisms infecting water and process system and creating increased human, animal, and environmental health risk.
In cooling towers, for example, water borne pathogenic microorganisms such as Legionella sp. may be present. If not properly treated with preferred biocides, aerosolized particles containing the microorganisms can create extreme health concerns from inhalation of the aerosolized microorganisms leading to disease such as Pontiac fever or the sometimes fatal Legionnaire's disease caused by Legionella pneumophila. Detection of this microorganism is difficult in the case of open recirculation water systems such as cooling towers because low concentrations represent serious health risk, and large water volumes must be concentrated into smaller sample volumes in order to perform the desired analytical test and obtain accurate and reproducible results.
SUMMARY OF THE INVENTION
The invention pertains to a method of treating a liquid sample having non-target microbiological particles, inorganic particles, and microbiological target species such as cells or viruses therein. The microbiological target species comprise target materials enveloped therein. The sample is passed through a prefilter medium to allow the target species to pass there through as filtrate. Some of the non-target biological particles and inorganic particles are retained on the prefilter medium. The filtrate from the prefiltering step is contacted by a main filtration medium that is adapted to retain the biological target species thereon as retentate along with other non-target microorganisms. The retentate from the main filtration step is lysed to form a lysate containing the target material.
In another aspect, the cell lysate passes through the main filtration medium and is further contacted by a post filtration medium to retain unlysed cells thereon while allowing passage of the target material therethrough as filtrate.
If desired, the main filtration medium may be pretreated with a retention enhancement agent or agents to improve the retainment of the microbiological target species on the main filter medium. In this case, the main filtration medium may be treated with a member or members chosen from the group consisting of surfactants, chelate reagents, salts, and organic solvents. These treatment agents both maintain the integrity of the microbiological target species therein (e.g., cells and viruses) during the main filter capture step and prevent the microbiological target species from irreversibly adhering to the filter material. This assures that a representative sample can be lysed and produce a testing sample that accurately represents the starting material.
DETAILED DESCRIPTION OF EXEMPLARY EMBODIMENTS
In one aspect, the present invention relates to a sample collection and processing method including filtration and lysis steps. In one exemplary embodiment, the method features membranes to filter high volumes of liquid quickly and collect target components in a liquid by a two-step method including a prefiltration step and a main filtration step. The process deploys a post-concentration mechanical or non-mechanical means to release the desired enveloped target material into the solution. The sample solution is then stabilized for downstream analysis. As used herein, microbiological target species may comprise cellular organisms such as bacteria, algae, fungi, prokaryotes, etc. or viruses. As is well known, in cellular material, the target material, nucleic acid such as DNA or RNA, is located inside the cell. In a virus, the nucleic acid is located with a protein coat. “Lysing”, as used herein, is then a rupturing of the cells or protein coat to release the desired target nucleic acid material.
The method, for example, may be used to measure microbiological content. Exemplary microorganisms such as bacteria, virus, algae, fungi, and prokaryotes may be measured in accordance with the method. The biological content to be processed in accordance with the methods may be derived from any water or process system such as process water, drinking water, municipal water, cooling water, personal care product manufacturing, in-process pharmaceutical, or food and beverage processes.
In one exemplary embodiment, membranes are employed in a prefiltration system to remove any inorganic particles and large biological particles. The prefiltration membrane or membranes do not retain the target species. This membrane can be any membrane of a variety of a variety of different materials and pore sizes, but preferably one with a controlled pore size that separates at a fixed dimension. Non-limiting examples of prefiltration membrane materials are nylon, stainless steel, cellulose esters, PTFE, glass fibers, polypropylene, polyvinylchloride, hydrophilic acrylic copolymers, polyether sulfones, polycarbonates, and polyesters. Membranes of different pore sizes can be applied depending on the desired end use application. Non-limiting examples of membrane pore size for the prefiltration system are from about 1 μm, to about 100 μm, more preferably from about 1 μm to about 50 μm, but any membrane that can be used as a prefilter using the instant methods should perform a similar function and should have a well-defined pore size, e.g., a mesh structure to assure that the loss of the target materials on the prefilter membrane is minimized.
In another aspect, plural prefiltration membranes can be provided and are arranged in an upstream to downstream flow orientation. The upstream membrane or membranes will have a higher porosity than the downstream membranes.
Although we do not desire to be held to any particular theory of operation or function, it appears that the prefilter serves two purposes. First, it captures larger particles, fungi, algae, and biofilm that, if allowed to transfer to the main membrane, could agglomerate with organics and small particles and inhibit flow. This results in either long filtration times or the inability to filter the total volume required to create a representative sample. Second, the prefilter traps larger life forms like amoeba that are known to harbor Legionella. In one embodiment, the test is for planktonic Legionella, and the amoeba would expel very large numbers of Legionella if lysed.
In one exemplary embodiment wherein Legionella pneumophila is the desired microbiological target species, a pair of nylon prefiltration membranes may be used with the upstream membrane in the pair having a pore size of about 20 μm with the downstream membrane having pores on the order of about 10-11 μm.
The main filtration medium comprises a membrane designed to retain the desired target species. This species may comprise cellular materials or viruses. This membrane can be any member of a different material or pore size. Nonlimiting examples of membranes that may be used as the main filtration medium are nylon, stainless steel, cellulose esters, PTFE, glass fiber, polypropylene, polyvinyl chloride, hydrophilic acrylic copolymer, polyethersulfone, polycarbonate, and polyester. The main filtration membrane functions to retain the target component thereon as retentate. At the same time, in another aspect of the invention, after the microbiological target species containing the target material therein are lysed, the lysate may be capable of passing through the main filtration medium for subsequent downstream assay or other process.
In one aspect of the invention, the lysate may be prevented from passing through the main membrane by placing a barrier on the bottom of the membrane. The lysing action may be performed by shaking, and the lysed product may be extracted through a post concentration membrane (e.g., PES 0.2 μm).
In those instances wherein the lysate is capable of passing through the main membrane, in one embodiment, the lysate could be recirculated in a closed system on multiple passes through the main filter for a predetermined recycling time. Then, the lysate continuing the target material nucleic acid could be removed from the recirculation system for subsequent analysis.
In one embodiment wherein Legionella pneumophila is the desired biological target material, glass fiber main filtration members may be used and those having pore sizes of between about 10 μm to about 3.0 μm may be mentioned as exemplary. More preferred are those main filter membranes having pore sizes on the order of between about 0.7 μm to about 2.7 μm.
The main membrane pore size requires consideration of two characteristics. First, it must retain the desired target species thereon while not allowing them to stick to the membrane and be lysed to release the enveloped target material during the concentration step. In that case, the target materials such as nucleic acids would be released during the concentration step and be passed with the filtrate. It is desired to keep the target species (e.g., cellular and viral) intact during the concentration step so that they can be lysed during the lysing step. Second, the membrane should have sufficient porosity to assure that a large volume of sample can be filtered in a time that is practical for efficient sample testing.
The main filter membrane, in accordance with one aspect of the invention, may be treated with chemical or fluidic retention enhancement agents such as surfactants, acids, bases, chelating reagents, salts, organic solvents, etc., to enhance target species retention on the main filtration medium while allowing practical sample flow through the membrane. Suitable surfactants include zwitterionic surfactants, anionic surfactants, cationic surfactants, and nonionic surfactants.
The filtration system including both the prefiltration and main filtration media can, in one embodiment, filter quantitative broad volumes of liquid samples with high flow rates. For example, an exemplary sample volume could be 10 liters or more. The sample could be filtered by an integral filtration system with gravity or pressure assistance. Filtration by pressure includes negative pressure and positive pressure. As is conventional in the art, pumps could be used to make negative pressure such as vacuum air pumps, diaphragm liquid pumps, peristatic pumps, etc.
The target species, such as microbiological contents retained by the main filtration medium, could be used for different applications like physical, chemical, and biological characterization, etc. In processing biological contents, the main membrane containing the desired target cells is exposed to a lysing buffer designed to produce a small volume of stabilized lysate containing nucleic acid and proteins, etc. for downstream detection such as Polymerase Chain Reaction (PCR), real time PCR, reverse transcription realtime PCR, etc. or other molecular test methods. Good integrity of the nucleic acid released from the target species can be obtained if the appropriate lysing material is used and can be stabilized in the lysate for 72 hours or more at temperatures of from about 4° C.-43° C.
Target species lysing occurs by cell or protein envelope rupture and can be classified as including non-mechanical or mechanical methods. Non-mechanical methods include chemical methods, thermal methods, enzymatic methods, etc. Mechanical methods include ultrasonic disruption using a homogenizer; pressing using, for example, a French press, etc., decompression, pulverization, etc.
For non-mechanical methods, a non-limiting example is a chemical lysis method that would include any suitable chemical that can disrupt cell or protein envelope barriers. Detergents are a non-limiting example of chemicals that are commonly used to disrupt a lipid double layer membrane to release cell contents and lyse membrane protein, and non-limiting examples of suitable lysing chemicals are lithium dodecyl sulfate, CHAPS, Tween-20E, NP40, CTAB, PVPP, Triton X series detergents, sodium cholate, and sodium deoxycholate, guanidinium hydrochloride, or caustic. Chaotropic agents like guanidiunium salts can also act as lysing agents in this system. The lysing efficiency of detergents and alternate lysing agents is dependent on the cell types and specific applications. Enzymes such as lysozymes, mutanolysin, labiase, lysostaphin, lyticase, proteinase K, endolysin and achromopeptidases may be included as lysing reagents or additives to enhance lysing. Organic solvents, such as DMSO, DMF could be also included as lysing reagents or additives to enhance lysing. A host of bioscience suppliers offer a wide collection of lysing buffers suitable for cell lysis application. A variety of physical methods such as shaking, heating, cutting and homogenizing, etc., could be employed in the process to enhance the lysing efficiency. Indeed in one embodiment a cutting action may be employed in which the cells may be ruptured and the main membrane itself will be cut. Based on the complexity of the application and the nature of the target species types, single or combinations of chemical lysis methods could be used in combination with mechanical methods.
To remove the interference from undesirable cell lysates and non-lysed cells, an additional membrane or membranes could be added to process the cell lysate for downstream application. The membrane could be any membrane of different materials whose pore size is in the range of 0.22 μm to 0.45 μm for bacterial, yeast, fungi, or protogen sampling. (Virus sampling will require smaller pore sizes). Non-limited examples of these “post” filtrations membrane materials are PVDF, PES, polycarbonate, nylon, etc. This membrane acts primarily to remove large materials and/or unlysed cells from the sample to enhance long term stability of the lysate at the conditions noted above.
Although the current description emphasizes a sample concentration and process method, it is clear that the methods could be applied to laboratory, field applications, on-line, automated batch, or off-line monitoring systems as well. This expansion of capabilities allows the system to be applied to both water and in-process monitoring, as well as final process or product monitoring. Additionally, this method should be readily adapted to process flows that are known to be susceptible to microbiological growth and is not limited to water systems. Processing food, beverage, and personal care products and other systems are within the scope of this invention.
The invention will be further described in the following examples which are to be regarded as being illustrative of the invention and should not be used to limit the claims.
Procedure
    • 1. Spike specific concentration (such as 10^4 CFU) of Legionella pneumophila cells and 10^6 CFU of Pseudomonas fluorescens into 500 ml of synthetic or field water. For field cooling water, 500 ml raw water without spiking was prepared.
    • 2. Filter 500 ml water sample through Nylon 20 μm (Millipore NY2004700) and Nylon 11 μm (Millipore NY1104700) to remove any particles and large biological contents while not retaining target contents.
    • 3. The filtrate from step 2 was concentrated by surfactant treated glass fiber 2.7 μm (Millipore APFD04700) to retain the target species contents.
    • 4. The main membranes from step 3 were added with 3 ml lysis buffer and lyzed for 5 minutes with the shaking speed of 100 round/minute. The lysis buffer solution comprises lithium lauryl sulfate, DMSO, and ethoxylated nonyl phenol.
    • 5. The lysates were filtered through PES 0.22 μm˜0.45 μm membranes for downstream analysis.
    • 6. For each process analysis on synthetic water, the controls are the same amount of target content detection by lysis without concentration.
    • 7. All the downstream analyses are RNA-based methods, except specific DNA-based real time PCR analysis mentioned in the results legends.
EXAMPLES Example 1 Membrane Screening
A variety of different membrane types were tested as prefilter or filter media so as to ensure that they were capable of filtering a 500 ml cooling water sample within a 10-minute time period. Tested, acceptable materials were found as follows.
Vendor Material Pore Size (μm)
— Stainless Steel 35
Millipore Polypropylene 25
Millipore Polypropylene 10
Millipore Nylon 20
Millipore PES 0.22
Millipore Glass fiber 1.6
Millipore Glass fiber 1.2
Millipore Glass fiber 2.7
Millipore Polypropylene 1.2
Millipore Polypropylene 2.5
Millipore Cellulose ester 1.2
Millipore Glass fiber 0.7
Millipore Glass Fiber 0.2-0.6
Millipore Glass Fiber 0.8-8.0
Millipore Glass Fiber 0.7
Millipore Nylon 0.45
Millipore Nylon 11
Millipore Nylon 11
Millipore Nylon 30
Millipore PES 0.22
Millipore Mixed cellulose esters 0.45
Millipore Mixed cellulose esters 8
Millipore PTFE 0.45
Millipore PTFE 5
Millipore PTFE 10
Millipore Glass fiber 2.7
Millipore PES 0.45
Millipore PVDF 0.22
Pall PP 10
Pall Acrylic 3
Pall Acrylic 0.45
Pall Acrylic 0.8
Pall PVC 5
GE Osmonics polycarbonate 0.1
GE Osmonics polycarbonate 0.4
GE Osmonics polycarbonate 1.0
GE Osmonics polycarbonate 0.2
GE Osmonics polycarbonate 12.0
GE Osmonics polycarbonate 1.0
GE Osmonics polycarbonate 2
GE Osmonics polycarbonate 3
GE Osmonics polycarbonate 5
GE Osmonics polycarbonate 10
GE Osmonics polycarbonate 20.0
GE Osmonics polyester 5
GE Osmonics polyester 0.4
GE Osmonics polyester 1.0
GE Osmonics polyester 10.0
GE Osmonics polyester 0.2
GE Osmonics PES 0.45
GE Osmonics PES 0.4
GE Osmonics PES 0.5
GE Osmonics PES 0.8
GE Osmonics PES 5
GE Osmonics PES 10.0
GE Osmonics PES 1.2
GE Osmonics PES 20.0
GE Osmonics Nylon 20.0
GE Osmonics Cellulose Acetate 0.45
GE Osmonics PVDF 0.22
GE Osmonics PVDF 0.45
GE Osmonics polypropylene 0.45
GE Osmonics polypropylene 0.22
Example 2 Prefilter, Main Filter System Test
The performance of a filtration system integrating a combination of Nylon 20 μm and Nylon 11 μm as the prefiltration membranes and a glass fiber 2.7 μm main filtration membrane was assessed to see if it could effectively provide filtration of a 500 ml cooling water sample within 10 minutes. The following results that were obtained indicate the percentage of filtrations passing the criteria versus total test runs. As can be seen in the results, the cooling water tested was taken from Chinese geographic locations and European locations.
The performance of filtration system integrating Nylon 20 μm, Nylon 11 μm as prefiltration membrane and glass fiber 2.7 μm as main membrane.
500 ml field sample flow rate summary (within 5 min)
Filter set
Prefiltration Main filtration Total
Prefilter-prefilter-main filter China EU China EU Prefiltration Main Filtration
NY20-NY11-GF2.7 94.1% (32/34) 80% (12/15) 97.1% (33/34) 86.7% (13/15) 89.8% (44/49) 93.9% (46.49)
Note:
No specific marked membranes are Millipore brand.
Number in parenthesis shows the number of samples that filtered in less than 10 minutes over the total number of samples.
Example 3 Prefiltration Testing
Candidate pre-filtration membranes were tested to ascertain their efficacy in allowing passage of the target material, Legionella pneumophila therethrough. Results are shown in terms of percentage of the desired target retained on the prefilter candidates.
Stainless Steel* 0.64%
Nylon 30 μm 0.31%
Millipore NY20 μm 0.38%
Millipore NY11 μm 1.46%
Nylon 20 μm 22.93% 
PES 20 μm 38.52% 
PC 10 μm 0.40%
PE 10 μm 0.19%
PES 10 μm 14.62% 
PC 5 μm 0.52%
PES 5 μm 15.68% 
Control  100%
*Vendor membranes that are not specifically identified are available from GE Osmonics.
Example 4 Main Membrane Screening for High Cell Retention
Main membrane candidates were screened to ascertain their effectiveness in retaining the desired target material, Legionella pneumophila thereon. RNA assay of the target remaining on the main filters was made.
Main membranes screening for high cell retention elucidated by natural log of RNA copies in cells.
Means of RNA Log STD of RNA Log
Membrane Copies Copies
GF2.7 7.13 0.07
GF1.6 7.25 0.07
GF1.2 7.02 0.15
GF0.7 7.03 0.12
PES0.45 7.19 0.08
Control 7.15 0.03
Example 5
Main membranes were assessed for cell detention after 5 minutes of contact with a lysing buffer system at the prescribed shaking rate noted above. RNA assay of retained cells was made in order to determine the percent yield.
500 ml - 5 min Lysis Yield (%) STD (%) RSD (%)
NY20-NY11-GF2.7 29.08% 6.69% 22.99%
NY20-NY11-GF1.6 22.32% 6.17% 27.66%
NY20-NY11-GF1.2 30.09% 8.92% 29.66%
NY11-NY1-GF0.7 18.54% 3.48% 18.77%
NY11-NY1-PES0.45 25.60% 3.41% 13.33%
Example 6 Shaking Speed and Lysis Time for Optimized Performance
A series of tests were undertaken to assess lysis solution contact time with the target material and shaking time of the main membrane and retained target. Yield percent was measured by RNA assay of the target material.
DoE Experiments to Determine the Shaking Speed and Lysis Time
Run A: Speed (50 rpm) B: Time (min) C: Volume (ml) Yield %
1 4 1 3 58.8
2 0 1 2 29.3
3 0 5 4 17.7
4 2 3 3 55.6
5 2 5 3 60.9
6 0 5 3 65.8
7 0 1 3 16.8
8 4 5 3 68.2
9 0 3 4 49.6
10 4 3 4 74.7
11 0 1 4 31.3
12 2 5 4 52
13 2 3 3 63.8
14 2 3 3 40.4
15 2 1 4 32.2
16 2 3 3 46.9
17 0 3 3 29.2
18 4 1 2 40.7
19 2 5 2 50.1
20 4 5 2 58.5
21 0 5 2 46.9
22 2 3 3 34.4
23 4 1 4 98.6
24 4 3 3 58.4
25 4 3 2 46.3
26 2 3 3 53.4
27 2 3 2 45.1
28 2 1 2 43.1
29 2 3 4 64.7
30 2 1 3 40.6
31 4 5 4 77.8
32 0 3 2 32.8
Optimal shaking speeds and lysis time were determined. Based on this data, an optimal shaking speed was determined at 2× or at 100 R.P.M. with a total lysis solution contact time of 5 minutes appearing optimal.
Example 7
The performance of membranes treated with a lysis buffering solution for 5 minutes was assessed. RNA assay was made to determine the amount of Legionella pneumophila in the lysate.
The performance of treated membrane with the optimized lysis buffer testing high concentrations of Legionella pneumophila (˜10^4 CFU/assay) cells.
Lysis Buffer STM STM + NP40 + DMSO
Membrane Treatment − + − +
RNA Log Copies 7.36 7.78 7.44 7.65
7.47 7.71 7.47 7.67
7.50 7.61 7.45 7.69
Mean 7.44 7.70 7.45 7.67
STD 0.08 0.08 0.02 0.02
STM = lithium lauryl sulfate
NP40 = nonyl phenol (40 EtO)
DMSO = dimethyl sulfoxide
− = no main filter pretreatment
+ = with main filter pretreatment
Example 8
Selected main filter membrane and lysis buffer performance were assessed at different concentrations of the target, Legionella pneumophila cells. No treatment indicates a lack of pretreatment of the filter. STM treatment indicates that the filter was pretreated with the lysis buffering solution.
The repeatability performance of the selected membrane and lysis buffer testing different concentrations of Legionella pneumophila cells.
STM STM + NP40 + DMSO
GF2.7 Mean STD Mean STD
10{circumflex over ( )}1 No treatment 4.06 0.20 3.93 0.02
STM treatment 4.32 0.13 4.33 0.19
10{circumflex over ( )}4 No treatment 6.71 0.02 6.70 0.02
STM treatment 6.89 0.01 6.89 0.08
Example 9
The repeatability of a device integrating the selected membrane and lysis buffer tested 5 log levels of Legionella pneumophila cells.
RNA Log
Copies Yield
CFU/L Mean STD Mean STD RSD
19 4.23 0.48 80.03% 68.48% 85.57%
190 5.00 0.12 24.21% 7.04% 29.08%
1900 5.87 0.03 22.03% 1.48% 6.72%
19000 6.90 0.12 20.50% 6.11% 29.81%
190000 8.18 0.11 16.91% 3.99% 23.62%
Example 10
Testing was undertaken to determine the effect of an additional filtering step, after the main filtering. After prefiltering and main filtering with lysing, the lysate was passed through a PES 0.22 μm filter to retain unlysed cells and pass lysate as filtrate.
Means of RNA
log copies STD of RNA log copies
Blank solution Negative /
Before filtration 5.53
through PES 0.22 5.47 5.48 0.05
Filter 5.44
After filtration 5.44
through PES 0.22 5.40 5.41 0.03
Filter 5.39
In certain exemplary aspects of the invention, the processes herein described takes less than 15 minutes from the time in which the sample collection is taken to obtain a stabilized biomaterial sample ready for transport to downstream testing. In other exemplary embodiments, stable extracts from the biomaterials are provided that retain stability for up to 72 hours at temperatures up to about 43° C.
In one exemplary embodiment, the prefiltration and main filtration steps are dead end filtering steps. Further, in varying embodiments, pretreatment of the main filter medium via surfactants or other retention enhancement agents may be employed. Surfactants may be present in concentration ranges of about 0.5% to about 5%. Further, when chelating reagents are utilized to pretreat the main filter membrane, these may be present in concentration of about 0.1 mM to 100 mM. These chelating reagents may comprise for example EDTA and EGTA etc. In further exemplary embodiments, salts may be used to pretreat the main filtration membrane, and these may be present in an amount of about 1-8 mM solutions, and in those cases in which organic solvents may be utilized for pretreatment of the main filtration medium, these may be present in an amount of about 1-10%.
Further, in order to improve lysing, the samples may be incubated at temperatures of about 30° C. to 100° C. Also, electrical fields may be employed to help release the intracellular material. Shaking, inverting, or vibration via impellers and the like may be utilized again as an aid or aids in the lysing operations. Shaking speeds of from about 10-350 RPM may be employed in those instances in which shaking may be found useful to enhance the lysing operation and the lysing operation may generally proceed for anywhere from about between 1 minute to 3 hours.
While we have shown and described herein certain embodiments of the invention, it is intended that there will be covered as well any change or modifications therein which may be made without the departing from the spirit and scope of the invention as defined in the appended claims.

Claims (18)

1. A method of treating a liquid sample having non-target microbiological particles, inorganic particles, and microbiological target species therein, wherein said microbiological target species are cellular microbiological organisms, and wherein said microbiological target species comprise target materials enveloped therein, said method comprising:
(a) passing said liquid sample through a prefilter medium to allow said microbiological target species to pass through as filtrate and to retain said non-target biological particles and said inorganic particles thereon;
(b) contacting said filtrate of (a) with a main filtration medium adapted to retain said microbiological species thereon as retentate, wherein the retention enhancement agent comprises a member or members selected from the group consisting of surfactants, chelate reagents, salts and organic solvents; wherein the retention enhancement agent maintains the integrity of the microbiological target species therein during the contacting step of (b) and prevents the microbiological target species from irreversibly adhering to the main filtration medium;
(c) lysing said retentate from step (b) on the main filtration medium to form a lysate containing said target materials; and
(d) contacting said lysate with a post filtration medium to retain any unlysed material thereon while allowing passage of said lysate therethrough as filtrate.
2. The method as recited in claim 1 wherein said target materials are intracellular nucleic acids.
3. The method as recited in claim 2 wherein said cellular microbiological organisms are selected from the group consisting of bacteria, algae, fungi, and prokaryotes.
4. The method as recited in claim 3 wherein said bacteria is Legionella pneumophila.
5. The method as recited in claim 4 wherein said prefilter medium comprises a filter membrane having pore sizes between about 1 μm to about 100 μm.
6. The method as recited in claim 4 wherein said main filtration medium comprises a filter membrane having pore sizes between about 0.01 μm to about 3.0 μm.
7. The method as recited in claim 6 wherein said main filtration medium comprises a filter membrane having pore sizes of between about 0.7 μm to about 2.7 μm.
8. The method as recited in claim 1 wherein said post filtration medium comprises a filter membrane having pore sizes between about 0.22 μm to about 0.45 μm.
9. The method as recited in claim 1 wherein said liquid sample is cooling water.
10. The method as recited in claim 1 wherein said lysate contains DNA.
11. The method as recited in claim 1 wherein said lysate contains RNA.
12. The method as recited in claim 1 wherein said step (c) comprises contacting said retentate with a lysing buffer solution.
13. The method as recited in 12 wherein said step (c) further comprises vibrating said retentate.
14. The method as recited in claim 1 wherein said step (c) comprises subjecting said retentate to ultrasonic vibration to aid in lysing said retentate.
15. The method as recited in claim 1 wherein said prefilter medium comprises a first nylon membrane and a second nylon membrane wherein the first nylon membrane is in an upstream flow orientation and the second nylon membrane is in a downstream flow orientation compared to the first nylon membrane, said first nylon membrane having pore sizes larger than the pores sizes of said second nylon membrane.
16. The method as recited in claim 15 wherein said first nylon membrane has pore sizes of about 20 μm and said second nylon membrane has pore sizes of about 10-11 μm.
17. The method as recited in claim 1 wherein said main filtration medium comprises a fiberglass filter membrane.
18. The method as recited in claim 1 wherein said retention enhancement agent comprises a member or members selected from the group consisting of surfactants in a concentration of about 0.5% to about 5%, chelate reagents in a concentration of about 0.1 mM to about 100 mM, salts in a concentration of about 1 mM to about 8 mM, and organic solvents in a concentration of about 1% to about 10%.
US12/215,768 2008-06-30 2008-06-30 Process for concentrating and processing fluid samples Expired - Fee Related US8158405B2 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
US12/215,768 US8158405B2 (en) 2008-06-30 2008-06-30 Process for concentrating and processing fluid samples
EP09774004A EP2303435A1 (en) 2008-06-30 2009-06-09 Process for concentrating and processing fluid samples
PCT/US2009/046755 WO2010002552A1 (en) 2008-06-30 2009-06-09 Process for concentrating and processing fluid samples
CN200980126140.0A CN102076400B (en) 2008-06-30 2009-06-09 Process for concentrating and processing fluid samples
BRPI0910202A BRPI0910202A2 (en) 2008-06-30 2009-06-09 method for treating a liquid sample
CA2728331A CA2728331A1 (en) 2008-06-30 2009-06-09 Process for concentrating and processing fluid samples
TW098120488A TW201009071A (en) 2008-06-30 2009-06-18 Process for concentrating and processing fluid samples
ARP090102286A AR072282A1 (en) 2008-06-30 2009-06-22 PROCESS TO CONCENTRATE AND PROCESS FLUID SAMPLES
CL2009001488A CL2009001488A1 (en) 2008-06-30 2009-06-26 Method for treating a liquid sample containing microbiological particles.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12/215,768 US8158405B2 (en) 2008-06-30 2008-06-30 Process for concentrating and processing fluid samples

Publications (2)

Publication Number Publication Date
US20090326211A1 US20090326211A1 (en) 2009-12-31
US8158405B2 true US8158405B2 (en) 2012-04-17

Family

ID=41152181

Family Applications (1)

Application Number Title Priority Date Filing Date
US12/215,768 Expired - Fee Related US8158405B2 (en) 2008-06-30 2008-06-30 Process for concentrating and processing fluid samples

Country Status (9)

Country Link
US (1) US8158405B2 (en)
EP (1) EP2303435A1 (en)
CN (1) CN102076400B (en)
AR (1) AR072282A1 (en)
BR (1) BRPI0910202A2 (en)
CA (1) CA2728331A1 (en)
CL (1) CL2009001488A1 (en)
TW (1) TW201009071A (en)
WO (1) WO2010002552A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8790916B2 (en) 2009-05-14 2014-07-29 Genestream, Inc. Microfluidic method and system for isolating particles from biological fluid

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102011105525B4 (en) 2011-06-24 2015-03-26 Sartorius Stedim Biotech Gmbh Process for separating biopolymer aggregates and viruses from a fluid
GB201617713D0 (en) 2016-10-19 2016-11-30 Q-Linea Ab Method for recovering microbial cells
CN109868205A (en) * 2017-12-05 2019-06-11 台达电子国际（新加坡）私人有限公司 Biological sample processing unit and its biological sample processing method
CN109306370A (en) * 2018-09-26 2019-02-05 浙江海洋大学 Detection method of DNA damage in copepods under nanomaterial stress
CN112305221A (en) * 2020-10-29 2021-02-02 海卫特(广州)医疗科技有限公司 Canine parvovirus detection kit and preparation method thereof
CN113136412A (en) * 2021-04-22 2021-07-20 浙江珂瑞康生物医疗科技有限公司 Biological load determination treatment liquid for biomedical material containing soluble protein

Citations (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4080294A (en) 1975-04-04 1978-03-21 Millipore Corporation Filtration system
US4137169A (en) 1976-11-12 1979-01-30 Filter Tech, Inc. Liquid filtration system
US4358535A (en) 1980-12-08 1982-11-09 Board Of Regents Of The University Of Washington Specific DNA probes in diagnostic microbiology
US4518402A (en) 1981-11-10 1985-05-21 Dargel Robert L Reuseable air filter system
US4976876A (en) 1988-03-14 1990-12-11 The Kendall Company Point-of-use membrane filtration system
US5096474A (en) 1989-12-13 1992-03-17 Air Systems International, Inc. Negative pressure filtration device
US5155018A (en) 1991-07-10 1992-10-13 Hahnemann University Process and kit for isolating and purifying RNA from biological sources
FR2693474A1 (en) 1992-07-09 1994-01-14 Garin Daniel Water contaminating microorganism sepn. and concn. to detect entero viruses - by on site sampling and tangential ultrafiltration for virus recovery
US5376527A (en) 1991-12-18 1994-12-27 Becton Dickinson And Company Process for lysing mycobacteria
US5456835A (en) 1993-11-08 1995-10-10 Hemasure, Inc. Device and process for removing free hemoglobin from blood
US5458782A (en) 1994-01-07 1995-10-17 Cuno Incorporated Hydrolytically stable nylon membrane
US5620790A (en) 1994-06-23 1997-04-15 Seitz-Filter-Werke Gmbh Und Co. Multi-layer microfiltration membrane having an integrated prefiltration layer and method of making same
US5643425A (en) * 1996-03-14 1997-07-01 Hoshizaki Denki Kabushiki Kaisha Saturated brine tank in apparatus for production of electrolyzed water
EP0389063B1 (en) 1989-03-23 1997-08-13 Akzo Nobel N.V. Process for isolating nucleic acid
US5658714A (en) 1991-02-28 1997-08-19 Abbott Laboratories Isolation of proteins by ultrafiltration
US5669946A (en) 1996-01-26 1997-09-23 Blair, Jr.; Earl W. Air particulate filtration device
US5783686A (en) 1995-09-15 1998-07-21 Beckman Instruments, Inc. Method for purifying nucleic acids from heterogenous mixtures
US5808041A (en) 1993-08-30 1998-09-15 Promega Corporation Nucleic acid purification using silica gel and glass particles
US5972613A (en) 1997-12-09 1999-10-26 The Perkin-Elmer Corporation Methods of nucleic acid isolation
US6015493A (en) 1997-07-14 2000-01-18 Teleparts International, Inc. Multiple filtration bypass method and apparatus for reducing particles in liquid distribution systems
WO2000027510A1 (en) 1998-11-10 2000-05-18 Asahi Kasei Kogyo Kabushiki Kaisha Method for filtration with membrane
US6110662A (en) * 1992-02-24 2000-08-29 Genelabs Technologies, Inc. HTLV-I/HTLV-II assay and method
US6136555A (en) * 1993-07-09 2000-10-24 Cambridge Molecular Technologies Limited Purification method and apparatus
US6312588B1 (en) 1998-11-09 2001-11-06 Fantom Technologies Inc. Water purifier
US6383818B1 (en) 1999-02-02 2002-05-07 Fuji Photo Film Co., Ltd. Method of analyzing blood component
WO2002036248A1 (en) 2000-10-26 2002-05-10 Prime Water Systems Gmbh Filtering device having a cylindrical first filter surrounding a membrane filtration unit
US6405875B1 (en) 1998-12-18 2002-06-18 Corning Incorporated Water filtration device and method
US6479273B1 (en) 1997-03-06 2002-11-12 Medigene Aktiengesellschaft Filtration method for separating viruses
US6508936B1 (en) 1997-10-01 2003-01-21 Saline Water Conversion Corporation Process for desalination of saline water, especially water, having increased product yield and quality
US6544751B1 (en) 1997-04-08 2003-04-08 Pall Corporation Methods of harvesting rare cells from blood products
US6544424B1 (en) 1999-12-03 2003-04-08 Refined Technology Company Fluid filtration system
US6551642B2 (en) 2001-03-08 2003-04-22 Cocotech, Inc. Process for removing oil from foodstuffs using a membrane filter
WO2003035234A1 (en) 2001-10-24 2003-05-01 Bin-X A/S Filtration system having hydrophilic capillary membranes
EP0958037B1 (en) 1996-11-11 2003-08-06 X-Flow B.V. Filtration membrane module
JP2003289899A (en) * 2002-04-03 2003-10-14 Aquas Corp Method for examining legionella bacterium in specimen
US20030201229A1 (en) 2002-02-04 2003-10-30 Martin Siwak Process for prefiltration of a protein solution
US20040033484A1 (en) * 2000-12-08 2004-02-19 Karl-Dieter Krenn Method and agent for determining total water hardness
US6821757B2 (en) 1998-05-27 2004-11-23 Qiagen Gmbh Rapid and simple process for isolation of circular nucleic acids
EP0979237B1 (en) 1997-02-24 2004-11-24 Stichting Sanquin Bloedvoorziening Method for removing viruses from protein solutions by nanofiltration
US20050115903A1 (en) 2002-04-09 2005-06-02 Genesystems Method and apparatus for extracting nucleic acids from a complex mixture
US6939697B2 (en) 2001-01-09 2005-09-06 Glaxosmithkline Biologicals, S.A. Process to concentrate insoluble proteins by vibrating membrane filtration
US6958392B2 (en) 1998-10-09 2005-10-25 Whatman, Inc. Methods for the isolation of nucleic acids and for quantitative DNA extraction and detection for leukocyte evaluation in blood products
WO2005115595A1 (en) 2004-05-31 2005-12-08 Entegris, Inc. Filtration membrane, filtration material and filter element
EP1710011A1 (en) 2005-04-07 2006-10-11 Gambro Lundia AB Filtration membrane
US20060263773A1 (en) 2004-11-30 2006-11-23 Kojiro Tanaka Measuring kit, measuring method and measuring apparatus of microorganism in liquid sample
WO2006129038A2 (en) 2005-06-03 2006-12-07 Veolia Eau - Compagnie Generale Des Eaux Method for quantifying living coliform microorganisms in a water sample
US20070003997A1 (en) * 2005-07-01 2007-01-04 Ebara Corporation Method and apparatus for detecting bacteria
WO2007004263A1 (en) 2005-06-30 2007-01-11 Ngk Insulators, Ltd. Filter
US20070098674A1 (en) * 2005-11-02 2007-05-03 Shmuel Bukshpan Compositions and methods for cell killing
US7220549B2 (en) 2004-12-30 2007-05-22 Helicos Biosciences Corporation Stabilizing a nucleic acid for nucleic acid sequencing
WO2007065229A1 (en) 2005-12-09 2007-06-14 Siemens Water Technologies Corp. Reduced backwash volume process
EP1624950B1 (en) 2003-05-19 2007-07-11 Millipore Corporation Process for prefiltration of a protein solution
US7252801B2 (en) 2001-11-27 2007-08-07 John Innes Coffey Method for controlling legionella in cooling towers
US20070185033A1 (en) * 1996-12-11 2007-08-09 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
US20070202770A1 (en) * 2004-03-26 2007-08-30 Penalva Joaquin E Production Method and Filter Comprising Non Woven Fabric and/or Filtering Injector Structures or Sheets Which are Obtained Using Said Method and Which are Intended for the Filtration and Which are Intended for the Filtration and Elimination of Legionella Pneumofila in any Installation at Risk From Legionella Pneumofila Proliferation
US20080013092A1 (en) * 2006-05-19 2008-01-17 George Maltezos Fluorescence detector, filter device and related methods
US7378238B2 (en) 2001-01-19 2008-05-27 Drm, Dr. Mueller Ag Method for treating biomass for producing cell lysate containing plasmid DNA
US7385040B2 (en) 2004-02-27 2008-06-10 Ge Healthcare Bio-Sciences Ab Antibody purification

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1308130A (en) * 2000-12-26 2001-08-15 李永武 Method of extracting nucleic and from microbe cell
CN1239471C (en) * 2003-10-20 2006-02-01 林坤华 Continuous amino acid producing process with fish processing waste water
US7547526B2 (en) * 2004-03-15 2009-06-16 Purdue Research Foundation Cell concentration and pathogen recovery

Patent Citations (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4080294A (en) 1975-04-04 1978-03-21 Millipore Corporation Filtration system
US4137169A (en) 1976-11-12 1979-01-30 Filter Tech, Inc. Liquid filtration system
US4358535A (en) 1980-12-08 1982-11-09 Board Of Regents Of The University Of Washington Specific DNA probes in diagnostic microbiology
US4358535B1 (en) 1980-12-08 1986-05-13
US4518402A (en) 1981-11-10 1985-05-21 Dargel Robert L Reuseable air filter system
US4976876A (en) 1988-03-14 1990-12-11 The Kendall Company Point-of-use membrane filtration system
EP0389063B1 (en) 1989-03-23 1997-08-13 Akzo Nobel N.V. Process for isolating nucleic acid
US5096474A (en) 1989-12-13 1992-03-17 Air Systems International, Inc. Negative pressure filtration device
US5658714A (en) 1991-02-28 1997-08-19 Abbott Laboratories Isolation of proteins by ultrafiltration
US5155018A (en) 1991-07-10 1992-10-13 Hahnemann University Process and kit for isolating and purifying RNA from biological sources
US5376527A (en) 1991-12-18 1994-12-27 Becton Dickinson And Company Process for lysing mycobacteria
US6110662A (en) * 1992-02-24 2000-08-29 Genelabs Technologies, Inc. HTLV-I/HTLV-II assay and method
FR2693474A1 (en) 1992-07-09 1994-01-14 Garin Daniel Water contaminating microorganism sepn. and concn. to detect entero viruses - by on site sampling and tangential ultrafiltration for virus recovery
US6136555A (en) * 1993-07-09 2000-10-24 Cambridge Molecular Technologies Limited Purification method and apparatus
US5808041A (en) 1993-08-30 1998-09-15 Promega Corporation Nucleic acid purification using silica gel and glass particles
US5456835A (en) 1993-11-08 1995-10-10 Hemasure, Inc. Device and process for removing free hemoglobin from blood
US5458782A (en) 1994-01-07 1995-10-17 Cuno Incorporated Hydrolytically stable nylon membrane
US5620790A (en) 1994-06-23 1997-04-15 Seitz-Filter-Werke Gmbh Und Co. Multi-layer microfiltration membrane having an integrated prefiltration layer and method of making same
US5783686A (en) 1995-09-15 1998-07-21 Beckman Instruments, Inc. Method for purifying nucleic acids from heterogenous mixtures
US5669946A (en) 1996-01-26 1997-09-23 Blair, Jr.; Earl W. Air particulate filtration device
US5643425A (en) * 1996-03-14 1997-07-01 Hoshizaki Denki Kabushiki Kaisha Saturated brine tank in apparatus for production of electrolyzed water
EP0958037B1 (en) 1996-11-11 2003-08-06 X-Flow B.V. Filtration membrane module
US20070185033A1 (en) * 1996-12-11 2007-08-09 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
EP0979237B1 (en) 1997-02-24 2004-11-24 Stichting Sanquin Bloedvoorziening Method for removing viruses from protein solutions by nanofiltration
US6838272B2 (en) 1997-03-06 2005-01-04 Switch Biotech Ag Filtration process for separating viruses
US6479273B1 (en) 1997-03-06 2002-11-12 Medigene Aktiengesellschaft Filtration method for separating viruses
US6544751B1 (en) 1997-04-08 2003-04-08 Pall Corporation Methods of harvesting rare cells from blood products
US6015493A (en) 1997-07-14 2000-01-18 Teleparts International, Inc. Multiple filtration bypass method and apparatus for reducing particles in liquid distribution systems
US6508936B1 (en) 1997-10-01 2003-01-21 Saline Water Conversion Corporation Process for desalination of saline water, especially water, having increased product yield and quality
US5972613A (en) 1997-12-09 1999-10-26 The Perkin-Elmer Corporation Methods of nucleic acid isolation
US6821757B2 (en) 1998-05-27 2004-11-23 Qiagen Gmbh Rapid and simple process for isolation of circular nucleic acids
US6958392B2 (en) 1998-10-09 2005-10-25 Whatman, Inc. Methods for the isolation of nucleic acids and for quantitative DNA extraction and detection for leukocyte evaluation in blood products
US6312588B1 (en) 1998-11-09 2001-11-06 Fantom Technologies Inc. Water purifier
WO2000027510A1 (en) 1998-11-10 2000-05-18 Asahi Kasei Kogyo Kabushiki Kaisha Method for filtration with membrane
US6405875B1 (en) 1998-12-18 2002-06-18 Corning Incorporated Water filtration device and method
US6383818B1 (en) 1999-02-02 2002-05-07 Fuji Photo Film Co., Ltd. Method of analyzing blood component
US6544424B1 (en) 1999-12-03 2003-04-08 Refined Technology Company Fluid filtration system
WO2002036248A1 (en) 2000-10-26 2002-05-10 Prime Water Systems Gmbh Filtering device having a cylindrical first filter surrounding a membrane filtration unit
US20040033484A1 (en) * 2000-12-08 2004-02-19 Karl-Dieter Krenn Method and agent for determining total water hardness
US6939697B2 (en) 2001-01-09 2005-09-06 Glaxosmithkline Biologicals, S.A. Process to concentrate insoluble proteins by vibrating membrane filtration
US7378238B2 (en) 2001-01-19 2008-05-27 Drm, Dr. Mueller Ag Method for treating biomass for producing cell lysate containing plasmid DNA
US6551642B2 (en) 2001-03-08 2003-04-22 Cocotech, Inc. Process for removing oil from foodstuffs using a membrane filter
WO2003035234A1 (en) 2001-10-24 2003-05-01 Bin-X A/S Filtration system having hydrophilic capillary membranes
US7252801B2 (en) 2001-11-27 2007-08-07 John Innes Coffey Method for controlling legionella in cooling towers
US20030201229A1 (en) 2002-02-04 2003-10-30 Martin Siwak Process for prefiltration of a protein solution
JP2003289899A (en) * 2002-04-03 2003-10-14 Aquas Corp Method for examining legionella bacterium in specimen
US20050115903A1 (en) 2002-04-09 2005-06-02 Genesystems Method and apparatus for extracting nucleic acids from a complex mixture
EP1624950B1 (en) 2003-05-19 2007-07-11 Millipore Corporation Process for prefiltration of a protein solution
US7385040B2 (en) 2004-02-27 2008-06-10 Ge Healthcare Bio-Sciences Ab Antibody purification
US20070202770A1 (en) * 2004-03-26 2007-08-30 Penalva Joaquin E Production Method and Filter Comprising Non Woven Fabric and/or Filtering Injector Structures or Sheets Which are Obtained Using Said Method and Which are Intended for the Filtration and Which are Intended for the Filtration and Elimination of Legionella Pneumofila in any Installation at Risk From Legionella Pneumofila Proliferation
WO2005115595A1 (en) 2004-05-31 2005-12-08 Entegris, Inc. Filtration membrane, filtration material and filter element
US20060263773A1 (en) 2004-11-30 2006-11-23 Kojiro Tanaka Measuring kit, measuring method and measuring apparatus of microorganism in liquid sample
US7220549B2 (en) 2004-12-30 2007-05-22 Helicos Biosciences Corporation Stabilizing a nucleic acid for nucleic acid sequencing
EP1710011A1 (en) 2005-04-07 2006-10-11 Gambro Lundia AB Filtration membrane
WO2006129038A2 (en) 2005-06-03 2006-12-07 Veolia Eau - Compagnie Generale Des Eaux Method for quantifying living coliform microorganisms in a water sample
US20090221013A1 (en) 2005-06-03 2009-09-03 Veolia Eau-Compagnie Generale Des Eaux Method for quantifying living coliform microorganisms in a water sample
WO2007004263A1 (en) 2005-06-30 2007-01-11 Ngk Insulators, Ltd. Filter
US20070003997A1 (en) * 2005-07-01 2007-01-04 Ebara Corporation Method and apparatus for detecting bacteria
US20070098674A1 (en) * 2005-11-02 2007-05-03 Shmuel Bukshpan Compositions and methods for cell killing
WO2007065229A1 (en) 2005-12-09 2007-06-14 Siemens Water Technologies Corp. Reduced backwash volume process
US20080013092A1 (en) * 2006-05-19 2008-01-17 George Maltezos Fluorescence detector, filter device and related methods

Non-Patent Citations (16)

* Cited by examiner, † Cited by third party
Title
"Assay", Wikipedia, http://en.www.wikipedia.org/wiki/Assay, Apr. 23, 2008, 3 pages.
"Legionella", Wikipedia, http://en.www.wikipedia.org/wiki/Legionella, May 30, 2008, 4 pages.
"RNA", Wikipedia, http://en.www.wikipedia.org/wiki/RNA, Jun. 6, 2008, 6 pages.
Amari, M. et al., "A Comparison of the Effect of PTFE and UPE Membrane Filters on the Quality of Photoresist Developers", Mykrolis, www.mykrolis.com, 2004, 9 pages.
Definition of surfactant from www.thefreedictionary.com/Soap+and+Detergent downloaded Apr. 24, 2011, 3 pages. *
Derwent abstract for NL 1021933 C6, published Dec. 2, 2007, downlaoded Apr. 24, 2011 from WEST. *
International Search Report issued in connection with corresponding PCT Application No. PCT/US2009/046755 on Nov. 3, 2009.
Lambert, K.J., "Pretreatment of Cells of 'Klebsiella pneumoniae' with 50% (v/v) Dimethylsulfoxide Yields Purified Deoxyribonucleic Acid of Low Polysaccharide Content", Agric. Biol. Chem., vol. 46, #12, 1982, pp. 3079-3080.
Law, K.A. et al., "Initial investigations into the ultrasonic lysis of microbial cells for the release of adenosine triphosphate", Analytical Biochemistry, vol. 317, 2003, pp. 266-267.
Lytle, C.D., et al., "Virus Passage through Track-Etch Membranes Modified by Salinity and a Nonionic Surfactant", Applied & Environ. Microbiology, vol. 65, #6, Jun. 1999, pp. 2773-2775.
Machine translation for JP 2003289899 (to Inoue et al.) published Oct. 14, 2003; downloaded Apr. 23, 2011 from JPO (13 pages). *
MSDS No. 74385-Nonident P40 Substitute, Fluka, Manufacturer: Sigma-Aldrich, Shanghai, China.
Nishiguchi, M.K., et al., "DNA Isolation Procedures", Methods and Tools in Bioscience and Medicine, 2002, pp. 249-287.
Taylor, M.T., et al., "Lysing Bacterial Spores by Sonication Through a Flexible Interface in a Microfluidic System", Analytical Chemistry, ACS Publications, vol. 73, #3, Feb. 1, 2001, pp. 492-496.
VanBavel, E., "Effects of Shear Stress on Endothelial Cells: Possible Relevance for Ultrasound Applications", Progress in Biophysics and Molecular Biology, vol. 93, 2007, pp. 374-383.
Yaradou Diaraf Farba et. al., Integrated real-time PCR for detection and monitoring of Legionella pneumophila in water systems, Applied and Environmental Microbiology, Mar. 2007, pp. 1452-1456, vol. 73, No. 5.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8790916B2 (en) 2009-05-14 2014-07-29 Genestream, Inc. Microfluidic method and system for isolating particles from biological fluid

Also Published As

Publication number Publication date
US20090326211A1 (en) 2009-12-31
TW201009071A (en) 2010-03-01
EP2303435A1 (en) 2011-04-06
CA2728331A1 (en) 2010-01-07
AR072282A1 (en) 2010-08-18
CN102076400B (en) 2015-07-22
BRPI0910202A2 (en) 2015-10-06
CL2009001488A1 (en) 2010-10-08
WO2010002552A1 (en) 2010-01-07
CN102076400A (en) 2011-05-25

Similar Documents

Publication Publication Date Title
US8158405B2 (en) Process for concentrating and processing fluid samples
US7893251B2 (en) Methods for selective isolation of nucleic acids from microbial cells present in samples containing higher eukaryotic cells and/or tissues
Brehm-Stecher et al. Sample preparation: the forgotten beginning
US9279121B2 (en) Nucleic acid processing kits and devices
Li et al. Rapid sample processing for detection of food-borne pathogens via cross-flow microfiltration
JP5259579B2 (en) Method for extracting deoxyribonucleic acid (DNA) from microorganisms that may be present in a blood sample
Barbosa et al. DNA extraction: finding the most suitable method
US20040101895A1 (en) Fta-coated media for use as a molecular diagnostic tool
WO2003016552A2 (en) Dna purification and recovery from high particulate and solids samples
US20100305312A1 (en) Method For The Extraction And Purification Of Nucleic Acids On A Membrane
KR20080066727A (en) Extraction method of RNA and detection method of RNA
KR20100017232A (en) Compositions, methods, and devices for isolating biological materials
Mueller et al. Variables influencing extraction of nucleic acids from microbial plankton (viruses, bacteria, and protists) collected on nanoporous aluminum oxide filters
CN101268198A (en) Methods for nucleic acid extraction and identification
WO2012031156A1 (en) Device for capture and lysis of microorganisms from liquids and methods of use thereof
US20160025607A1 (en) Sample concentrator and method of use
US20120282623A1 (en) Rapid pathogen detection techniques and apparatus
US20210180116A1 (en) Assay using multi-layer membrane to detect microbiological target and method of manufacturing multi-layer membrane
Lee et al. Chemical trends in sample preparation for nucleic acid amplification testing (NAAT): A review
Shin Nucleic acid extraction and enrichment
WO2000062023A1 (en) Fta-coated media for use as a molecular diagnostic tool
CN109706143A (en) A kind of extracting method of peripheral blood high molecular weight genomic DNA
WO2017116695A1 (en) Assembly and method for field filtration of water samples
CA2739728A1 (en) Recovery and detection of microorganisms from mixed cellulose ester filtration supports by sequential treatment with methanol and acetone
Waterhouse The retention testing of sterilising grade membranes with Pseudomonas diminuta

Legal Events

Date Code Title Description
AS Assignment

Owner name: GENERAL ELECTRIC COMPANY, NEW YORK

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:BOYETTE, SCOTT;XU, RONG;LUO, JING;AND OTHERS;REEL/FRAME:021670/0942;SIGNING DATES FROM 20080721 TO 20080724

Owner name: GENERAL ELECTRIC COMPANY, NEW YORK

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:BOYETTE, SCOTT;XU, RONG;LUO, JING;AND OTHERS;SIGNING DATES FROM 20080721 TO 20080724;REEL/FRAME:021670/0942

STCF Information on status: patent grant

Free format text: PATENTED CASE

CC Certificate of correction
FPAY Fee payment

Year of fee payment: 4

AS Assignment

Owner name: BL TECHNOLOGIES, INC., MINNESOTA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:GENERAL ELECTRIC COMPANY;REEL/FRAME:047502/0065

Effective date: 20170929

MAFP Maintenance fee payment

Free format text: PAYMENT OF MAINTENANCE FEE, 8TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1552); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

Year of fee payment: 8

FEPP Fee payment procedure

Free format text: MAINTENANCE FEE REMINDER MAILED (ORIGINAL EVENT CODE: REM.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

LAPS Lapse for failure to pay maintenance fees

Free format text: PATENT EXPIRED FOR FAILURE TO PAY MAINTENANCE FEES (ORIGINAL EVENT CODE: EXP.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362

FP Lapsed due to failure to pay maintenance fee

Effective date: 20240417